Nonetheless, the generalizability of these findings in human breast cancer remains uncertain, as gene expression analysis in a cohort of breast cancer patients from France did not show RSPO3 overexpression to occur with an appreciable frequency [25] (1/446 patients). The gene discussed is RSPO3; the disease is breast cancer.